The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial (Q24595579)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial
scientific article

    Statements

    The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial (English)
    0 references
    Martin Dennis
    0 references
    Geoff Cohen
    0 references
    Karen Innes
    0 references
    Graham Venables
    0 references
    Stefano Ricci
    0 references
    Veronica Murray
    0 references
    Karsten Bruins Slot
    0 references
    Manuel Correia
    0 references
    Andre Peeters
    0 references
    Stephen J Phillips
    0 references
    Antonio Arauz
    0 references
    23 June 2012
    0 references
    0 references
    379
    0 references
    9834
    0 references
    2352-63
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit